Brevet, innovation modulaire et collaboration. Le cas des vaccins géniques

Antoine Bureth, Moritz Müller, Julien Pénin () and Sandrine Wolf

Revue d'économie industrielle, 2007, vol. n° 120, issue 4, 8-8

Abstract: Beyond their function of protecting and rewarding innovation, patents are increasingly used as mediation instruments and as vehicles for interactions. Focusing on the development of new, genetically engineered vaccines, we show that they are central components of the production of innovation. A genetically engineered vaccine is constituted by three basic modules: the antigen, the vector and the adjuvant. The advent of genetic engineering techniques promotes the autonomous development of each of these blocks at the technical as well as the organizational and the cognitive levels. Patents become therefore strategic instruments and negotiation devices throughout the elaboration of product architecture. They act as an interface between heterogeneous organizations, technological trajectories and corpus of knowledge.

Keywords: Intellectual Property Rights; Vaccine; Modularity; Collective Innovation (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=REI_120_0008 (application/pdf)
http://www.cairn.info/revue-d-economie-industrielle-2007-4-page-8.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:reidbu:rei_120_0008

Access Statistics for this article

More articles in Revue d'économie industrielle from De Boeck Université
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().